A Penn State researcher is part of the team that developed techniques that have generated insights into dietary divergences between some of our human ancestors, allowing scientists to better understand the evolutionary path that led to the modern-day diets that humans consume. “Our new techniques are allowing us to get beyond simple dichotomies and helping us understand the processes by which dietary evolution is working,” said Peter Ungar, professor of anthropology at the University of Arka
UCB today announced positive results for the two pivotal Phase III trials (PRECISE 1 and 2) of certolizumab pegol (CDP870) in the induction and maintenance of clinical response in moderate to severe active CrohnTMs disease. The PRECiSE trials assessed the safety and efficacy of CIMZIATM compared to placebo over a 26 week period, in a total of 1330 patients with active CrohnTMs disease.
Data from PRECiSE 1 and 2 will be presented in more detail at the major forthcoming gastroent
Scientists from the Flanders Interuniversity Institute for Biotechnology (VIB) associated with the University of Antwerp have achieved a new breakthrough in their research on the origins of Alzheimer’s disease. Their alternative approach opens up new prospects for developing a treatment which can slow the disease’s progress. The researchers have shown that ´the plaques´ which form in the brain of patients are linked to damage to nearby blood vessels. Leakage appears to occur between the blood vesse
Measuring the biochemical changes in breast tumors with magnetic resonance (MR) spectroscopy enables radiologists to more accurately distinguish benign tumors from cancerous ones, according to a study appearing in the August issue of the journal Radiology.
“Adding spectroscopy to breast MR examinations will not only reduce concern over possible missed cancers and unnecessary biopsy procedures, it may also improve the efficiency and quality of patient care,” said co-author Si
Cholesterol-lowering statin therapy may improve survival in patients with diastolic heart failure (DHF) according to a paper published in Circulation: Journal of the American Heart Association by cardiologists at Wake Forest University Baptist Medical Center.
Currently, there are no treatments shown to improve survival in these patients, who make up about 40 percent of all heart failure cases. Systolic heart failure patients have hearts that dont pump out enough blood. I
A portable, versatile and low-cost molecular detection tool being developed by a team of European researchers promises to revolutionise the diagnosis of diseases such as cancer and open up new applications in sectors as diverse as environmental protection, chemical analysis and food safety.
Working in the field of micro- and nano-technologies, the IST programme-funded BioFinger project is due to begin testing its state-of-the-art system over the summer amid expectations for a c
Gene scanning techniques developed by Professor Ian Day and colleagues at the University of Southampton are set to have a major impact on healthcare in the future.
One of two gene mutation scanning techniques devised by Professor Day and his team in the Human Genetics Division of the University’s School of Medicine has been successfully applied to search for rare genetic mutations in the population at large.
Their method, called meltMADGE, which combines thermal ramp el